The Co-Encapsulated Antioxidant Nanoparticles of Ellagic Acid and Coenzyme Q10 Ameliorates Hyperlipidemia in High Fat Diet Fed Rats 

 -  Journal of NanoScience and Nanotechnology, 9(11), p.6741-6746, 2009 .
<br/><br/> Obesity is the major cause of type 2 diabetes with hyperlipidemia as one of its complications and antioxidants were found to be beneficial in such disease conditions. The present investigation is geared towards reduction of the dose required/improve the bioavailability of the combination of antioxidants, ellagic acid and coenzyme Q10 by co-encapsulating them into nanoparticles and study the possible synergism in ameliorating hyperlipidemia in high fat diet fed rats. The co-encapsulated particles at 10 
<br/><br/><label>Subjects--Topical Terms: </label><br/>ANTIOXIDANTS<br/>HYPERLIPIDEMIA<br/>NANOPARTICLES<br/>BIOAVAILABILITY